SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-033141
Filing Date
2023-11-29
Accepted
2023-11-29 07:00:38
Documents
14
Period of Report
2023-11-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20231128_8k.htm   iXBRL 8-K 31159
2 EXHIBIT 99.1 ex_600925.htm EX-99.1 11206
  Complete submission text file 0001437749-23-033141.txt   193927

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20231129.xsd EX-101.SCH 3875
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20231129_def.xml EX-101.DEF 13418
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20231129_lab.xml EX-101.LAB 17618
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20231129_pre.xml EX-101.PRE 13395
8 EXTRACTED XBRL INSTANCE DOCUMENT bcda20231128_8k_htm.xml XML 4323
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 231448425
SIC: 2836 Biological Products, (No Diagnostic Substances)